INGR
VENTE TOTALE: 1 662 titres (~170 039,22 $ US)
- Insiders
- Fischer David B
- Total bought
- —
- Total sold
- $170,039
- Last activity
- 2026-08-05
- Last synced
-
2026-08-11 09:46:50
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bullish signal Scored 2026-08-07
INGR combines robust financial health (liquidity: 90, fundamentals: 85) with a confirmed Q2 2026 earnings beat and 7% volume growth in its high-value Texture & Healthful Solutions segment, supported by institutional…
The first sentence of the analysis written for INGR on 2026-08-07 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 25.3% | 24.1% | 21.4% | 18.8% | 19.3% | |
| Ebit Margin | 14.0% | 13.1% | 11.7% | 9.7% | 4.7% | |
| Ebitda Margin | 17.1% | 15.9% | 14.4% | 12.4% | 7.9% | |
| Operating Profit Margin | 14.4% | 11.9% | 11.7% | 9.6% | 4.5% | |
| Pretax Profit Margin | 13.5% | 12.5% | 10.3% | 8.4% | 3.6% | |
| Continuous Operations Profit Margin | 10.2% | 8.8% | 8.0% | 6.3% | 1.8% | |
| Net Profit Margin | 10.1% | 8.7% | 7.9% | 6.2% | 1.7% | |
| Bottom Line Profit Margin | 10.1% | 8.7% | 7.9% | 6.2% | 1.7% | |
| Current Ratio | 2.663 | 2.619 | 1.918 | 1.758 | 1.784 | |
| Quick Ratio | 1.731 | 1.692 | 1.100 | 0.910 | 1.009 | |
| Solvency Ratio | 0.269 | 0.242 | 0.216 | 0.164 | 0.089 | |
| Cash Ratio | 0.783 | 0.778 | 0.226 | 0.125 | 0.217 | |
| Price To Earnings Ratio | 9.706 | 13.923 | 11.143 | 13.180 | 55.540 | |
| Price To Earnings Growth Ratio | 0.648 | 9.686 | 0.358 | 0.040 | -0.836 | |
| Forward Price To Earnings Growth Ratio | 0.648 | 9.686 | 0.358 | 0.040 | -0.836 | |
| Price To Earnings Diluted Ratio | 9.862 | 14.167 | 11.305 | 13.342 | 55.861 | |
| Price To Earnings Diluted Growth Ratio | 0.651 | 12.364 | 0.367 | 0.041 | -0.841 | |
| Price To Book Ratio | 1.632 | 2.332 | 1.994 | 2.029 | 2.068 | |
| Price To Sales Ratio | 0.981 | 1.213 | 0.878 | 0.816 | 0.941 | |
| Price To Free Cash Flow Ratio | 13.853 | 7.938 | 9.667 | -43.804 | 70.484 | |
| Price To Operating Cash Flow Ratio | 7.499 | 6.274 | 6.777 | 42.651 | 16.542 | |
| Debt To Assets Ratio | 0.227 | 0.273 | 0.314 | 0.354 | 0.321 | |
| Debt To Equity Ratio | 0.413 | 0.527 | 0.668 | 0.838 | 0.717 | |
| Debt To Capital Ratio | 0.292 | 0.345 | 0.401 | 0.456 | 0.417 | |
| Long Term Debt To Capital Ratio | 0.287 | 0.316 | 0.326 | 0.378 | 0.357 | |
| Financial Leverage Ratio | 1.820 | 1.927 | 2.127 | 2.367 | 2.232 | |
| Working Capital Turnover Ratio | 3.387 | 4.015 | 5.344 | 6.084 | 5.808 | |
| Operating Cash Flow Ratio | 0.717 | 1.121 | 0.597 | 0.081 | 0.259 | |
| Operating Cash Flow Sales Ratio | 0.131 | 0.193 | 0.130 | 0.019 | 0.057 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.541 | 0.790 | 0.701 | -0.974 | 0.235 | |
| Debt Service Coverage Ratio | 11.706 | 10.928 | 1.751 | 1.271 | 1.097 | |
| Interest Coverage Ratio | 28.027 | 22.641 | 8.395 | 7.697 | 4.189 | |
| Short Term Operating Cash Flow Coverage Ratio | 19.667 | 32.636 | 2.359 | 0.280 | 1.273 | |
| Operating Cash Flow Coverage Ratio | 0.527 | 0.706 | 0.440 | 0.057 | 0.174 | |
| Capital Expenditure Coverage Ratio | 2.180 | 4.771 | 3.345 | 0.507 | 1.307 | |
| Dividend Paid And Capex Coverage Ratio | 1.466 | 2.810 | 2.073 | 0.316 | 0.810 | |
| Dividend Payout Ratio | 0.289 | 0.325 | 0.302 | 0.368 | 1.573 | |
| Enterprise Value Multiple | 6.357 | 8.487 | 7.818 | 9.088 | 15.505 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 25.3% | ▲1.2% | ▲3.5% |
| Ebit Margin | 14.0% | ▲0.9% | ▲3.4% |
| Ebitda Margin | 17.1% | ▲1.1% | ▲3.6% |
| Operating Profit Margin | 14.4% | ▲2.5% | ▲4.0% |
| Pretax Profit Margin | 13.5% | ▲1.0% | ▲3.8% |
| Continuous Operations Profit Margin | 10.2% | ▲1.4% | ▲3.2% |
| Net Profit Margin | 10.1% | ▲1.4% | ▲3.2% |
| Bottom Line Profit Margin | 10.1% | ▲1.4% | ▲3.2% |
| Current Ratio | 2.663 | ▲0.044 | ▲0.515 |
| Quick Ratio | 1.731 | ▲0.039 | ▲0.443 |
| Solvency Ratio | 0.269 | ▲0.027 | ▲0.073 |
| Cash Ratio | 0.783 | ▲0.004 | ▲0.357 |
| Price To Earnings Ratio | 9.706 | ▼-4.217 | ▼-10.992 |
| Price To Earnings Growth Ratio | 0.648 | ▼-9.039 | ▼-1.331 |
| Forward Price To Earnings Growth Ratio | 0.648 | ▼-9.039 | ▼-1.331 |
| Price To Earnings Diluted Ratio | 9.862 | ▼-4.305 | ▼-11.045 |
| Price To Earnings Diluted Growth Ratio | 0.651 | ▼-11.712 | ▼-1.865 |
| Price To Book Ratio | 1.632 | ▼-0.700 | ▼-0.379 |
| Price To Sales Ratio | 0.981 | ▼-0.232 | ▲0.015 |
| Price To Free Cash Flow Ratio | 13.853 | ▲5.914 | ▲2.225 |
| Price To Operating Cash Flow Ratio | 7.499 | ▲1.224 | ▼-8.450 |
| Debt To Assets Ratio | 0.227 | ▼-0.047 | ▼-0.071 |
| Debt To Equity Ratio | 0.413 | ▼-0.114 | ▼-0.220 |
| Debt To Capital Ratio | 0.292 | ▼-0.053 | ▼-0.090 |
| Long Term Debt To Capital Ratio | 0.286 | ▼-0.030 | ▼-0.046 |
| Financial Leverage Ratio | 1.820 | ▼-0.106 | ▼-0.274 |
| Working Capital Turnover Ratio | 3.387 | ▼-0.628 | ▼-1.541 |
| Operating Cash Flow Ratio | 0.717 | ▼-0.404 | ▲0.162 |
| Operating Cash Flow Sales Ratio | 0.131 | ▼-0.062 | ▲0.025 |
| Free Cash Flow Operating Cash Flow Ratio | 0.541 | ▼-0.249 | ▲0.283 |
| Debt Service Coverage Ratio | 11.706 | ▲0.778 | ▲6.355 |
| Interest Coverage Ratio | 28.027 | ▲5.386 | ▲13.837 |
| Short Term Operating Cash Flow Coverage Ratio | 19.667 | ▼-12.970 | ▲8.424 |
| Operating Cash Flow Coverage Ratio | 0.527 | ▼-0.178 | ▲0.146 |
| Capital Expenditure Coverage Ratio | 2.180 | ▼-2.591 | ▼-0.242 |
| Dividend Paid And Capex Coverage Ratio | 1.466 | ▼-1.344 | ▼-0.029 |
| Dividend Payout Ratio | 0.289 | ▼-0.035 | ▼-0.282 |
| Enterprise Value Multiple | 6.357 | ▼-2.129 | ▼-3.094 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $7.08B | $9.01B | $7.16B | $6.48B | $6.48B | |
| Enterprise value | $7.84B | $10.05B | $9.16B | $8.92B | $8.40B | |
| EV / Sales | 1.09x | 1.35x | 1.12x | 1.12x | 1.22x | |
| EV / Op. cash flow | 8.30x | 7.00x | 8.67x | 58.71x | 21.44x | |
| EV / Free cash flow | 15.34x | 8.85x | 12.37x | -60.30x | 91.34x | |
| EV / EBITDA | 6.36x | 8.49x | 7.82x | 9.09x | 15.51x | |
| Net debt / EBITDA | 0.62x | 0.88x | 1.71x | 2.49x | 3.54x | |
| Current ratio | 2.66x | 2.62x | 1.92x | 1.76x | 1.78x | |
| Income quality | 1.29x | 2.22x | 1.64x | 0.30x | 3.35x | |
| Graham number | $131 | $115 | $109 | $90 | $43 | |
| Graham net-net | -$17 | -$17 | -$29 | -$33 | -$30 | |
| Tax burden | 74.8% | 69.5% | 76.6% | 73.7% | 47.2% | |
| Interest burden | 96.3% | 96.0% | 88.0% | 87.1% | 77.0% | |
| Working capital | $2.19B | $2.07B | $1.63B | $1.43B | $1.19B | |
| Invested capital | $5.98B | $5.60B | $5.30B | $5.13B | $4.96B | |
| Return on assets | 9.2% | 8.7% | 8.4% | 6.5% | 1.7% | |
| Operating ROA | 13.5% | 11.7% | 12.6% | 10.5% | 4.5% | |
| Return on tangible assets | 11.0% | 10.5% | 10.1% | 7.9% | 2.1% | |
| Return on equity | 16.8% | 16.7% | 17.9% | 15.4% | 3.7% | |
| Return on invested capital | 11.8% | 9.9% | 11.6% | 9.1% | 2.7% | |
| Return on capital employed | 15.8% | 14.3% | 16.3% | 13.4% | 5.6% | |
| Earnings yield | 10.3% | 7.2% | 9.0% | 7.6% | 1.8% | |
| Free cash flow yield | 7.2% | 12.6% | 10.3% | -2.3% | 1.4% | |
| Capex / Op. cash flow | 45.9% | 21.0% | 29.9% | 197.4% | 76.5% | |
| Capex / Depreciation | 195.0% | 140.7% | 144.3% | 139.5% | 136.4% | |
| Capex / Sales | 6.0% | 4.1% | 3.9% | 3.8% | 4.4% | |
| SG&A / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.0% | 0.6% | 0.2% | 0.4% | 0.3% | |
| Intangibles / Total assets | 16.1% | 17.0% | 17.1% | 17.2% | 19.3% | |
| Days sales outstanding | 52d | 54d | 57d | 65d | 60d | |
| Days payables outstanding | 86d | 39d | 44d | 49d | 51d | |
| Operating cycle | 135d | 131d | 140d | 155d | 137d | |
| Cash conversion cycle | 49d | 91d | 95d | 106d | 86d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-09-25 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-07-10 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-06-24 | Lisa McClain | Purchase | $1,001 - $15,000 |
Recent news
- 2026-08-05 Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth Ingredion beats Q2 estimates as 7% Texture & Healthful Solutions volume growth and FX gains offset Argo issues and higher costs.
- 2026-08-05 Amundi Boosts Stake in Ingredion Incorporated $INGR Amundi grew its holdings in shares of Ingredion Incorporated (NYSE: INGR) by 19.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 142,282 shares of the company''s stock after acquiring an additional 23,122 shares during the quarter. Amundi owned
- 2026-08-05 Ingredion Incorporated $INGR Shares Purchased by California State Teachers Retirement System California State Teachers Retirement System raised its position in Ingredion Incorporated (NYSE: INGR) by 27.0% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 76,804 shares of the company''s stock after purchasing an additional 16,333 shares during the quarter. California State Teachers
- 2026-08-05 Ingredion Q2 Earnings Call Highlights Ingredion (NYSE: INGR) reported second-quarter 2026 results that were in line with its expectations, as continued growth in Texture and Healthful Solutions offset operational and macroeconomic pressures in other parts of the portfolio. Second-quarter net sales increased 1% year over year to $1.85 billion. Reported operating income was $188 million, while adjusted operating income declined 5%
- 2026-08-05 Ingredion Q2 Earnings Call Highlights Ingredion NYSE: INGR reported second-quarter 2026 results that were in line with its expectations, as continued growth in Texture & Healthful Solutions offset operational and macroeconomic pressures in other parts of the portfolio.
- 2026-08-04 Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript
- 2026-08-04 Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates Ingredion (INGR) came out with quarterly earnings of $2.82 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.87 per share a year ago.
- 2026-08-04 Ingredion Incorporated Reports Second Quarter 2026 Results Second quarter 2026 reported and adjusted* operating income decreased 31% and 5% compared to the second quarter 2025 Second quarter 2026 reported and adjusted EPS were $1.78 and $2.82, compared with $2.99 and $2.87 in the second quarter 2025 Reaffirming amended full-year guidance, which now reflects the sale of a majority stake in the Pakistan business, for reported EPS to be in the range of $9.15 to $9.75 and adjusted EPS to be in the range of $10.30 to $10.90 Ingredion''s 595 pence all-cash offer to acquire Tate & Lyle accepted by their shareholders WESTCHESTER, Ill., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its second quarter 2026 results.
- 2026-08-03 Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk? Ingredion''s cheap valuation and growing specialty business support the bull case, but Argo execution risks and weaker guidance argue for patience.
- 2026-08-03 How Ingredion''s Tate & Lyle Deal Could Reshape Its Growth Outlook Ingredion''s proposed $5 billion Tate & Lyle deal could expand its specialty platform and global reach, but approvals and integration risks remain.